Promisia Healthcare (PHL) H2 2026 earnings summary

Executive summary

• Achieved material improvement across all key financial and operational metrics, driven by focused execution, strategic priorities, and strengthened leadership.

• Delivered strong performance through higher occupancy, operational discipline, and successful integration of new sites, with Cromwell operations contributing for the full year.

• Underlying EBITDAF increased 58% to $6.6 million, and net profit after tax surged 89% to $12.9 million, reflecting operational improvements and fair value gains.

• Group care occupancy improved from 87% to 94%, with all facilities contributing to the uplift.

Financial highlights

• Operating revenue rose 29% year-over-year to $40.1 million, supported by higher occupancy and full-year Cromwell trading.

• Underlying EBITDAF increased 58% to $6.6 million compared to FY25.

• Net operating cash flows grew 87% year-over-year to $6.4 million.

• NTA per share climbed 38% to $1.09, more than doubling over three years.

• Portfolio valuation increased 17.1% to $107.2 million, with all five sites seeing at least 10% value uplift.

Outlook and guidance

• Underlying EBITDAF for FY27 expected to reach at least $8.0 million, over 20% year-over-year growth.

• Group care occupancy targeted to rise to at least 95%.

• Operating free cash flow projected to materially improve, supporting dividend payments and reinvestment.

• Actively pursuing an earnings-accretive acquisition in FY27; guidance excludes impact of future acquisitions.